These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 37552657)
41. Clinical and histopathological predictors of outcome in malignant meningioma. Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425 [TBL] [Abstract][Full Text] [Related]
42. Comparison of machine learning classifiers for differentiation of grade 1 from higher gradings in meningioma: A multicenter radiomics study. Hamerla G; Meyer HJ; Schob S; Ginat DT; Altman A; Lim T; Gihr GA; Horvath-Rizea D; Hoffmann KT; Surov A Magn Reson Imaging; 2019 Nov; 63():244-249. PubMed ID: 31425811 [TBL] [Abstract][Full Text] [Related]
43. A radiomics model enables prediction venous sinus invasion in meningioma. Wang L; Cao Y; Zhang G; Sun D; Zhou W; Li W; Zhou J; Chen K; Zhang J Ann Clin Transl Neurol; 2023 Aug; 10(8):1284-1295. PubMed ID: 37408500 [TBL] [Abstract][Full Text] [Related]
44. Ultrarapid Evaluation of Meningioma Malignancy by Intraoperative Flow Cytometry. Matsuoka G; Eguchi S; Anami H; Ishikawa T; Yamaguchi K; Nitta M; Muragaki Y; Kawamata T World Neurosurg; 2018 Dec; 120():320-327. PubMed ID: 30144616 [TBL] [Abstract][Full Text] [Related]
45. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Roser F; Samii M; Ostertag H; Bellinzona M Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263 [TBL] [Abstract][Full Text] [Related]
46. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes. Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828 [TBL] [Abstract][Full Text] [Related]
47. Deep Learning Model for the Automated Detection and Histopathological Prediction of Meningioma. Zhang H; Mo J; Jiang H; Li Z; Hu W; Zhang C; Wang Y; Wang X; Liu C; Zhao B; Zhang J; Zhang K Neuroinformatics; 2021 Jul; 19(3):393-402. PubMed ID: 32974873 [TBL] [Abstract][Full Text] [Related]
48. A radiomics model for preoperative prediction of brain invasion in meningioma non-invasively based on MRI: A multicentre study. Zhang J; Yao K; Liu P; Liu Z; Han T; Zhao Z; Cao Y; Zhang G; Zhang J; Tian J; Zhou J EBioMedicine; 2020 Aug; 58():102933. PubMed ID: 32739863 [TBL] [Abstract][Full Text] [Related]
49. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844 [TBL] [Abstract][Full Text] [Related]
50. Predicting Histologic Grade of Meningiomas Using a Combined Model of Radiomic and Clinical Imaging Features from Preoperative MRI. Park JH; Quang LT; Yoon W; Baek BH; Park I; Kim SK Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137489 [TBL] [Abstract][Full Text] [Related]
51. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas. Winther TL; Torp SH J Neurooncol; 2017 Feb; 131(3):575-583. PubMed ID: 27868157 [TBL] [Abstract][Full Text] [Related]
52. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas. Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361 [TBL] [Abstract][Full Text] [Related]
53. Peritumoral Brain Edema in Meningiomas Depends on Aquaporin-4 Expression and Not on Tumor Grade, Tumor Volume, Cell Count, or Ki-67 Labeling Index. Gawlitza M; Fiedler E; Schob S; Hoffmann KT; Surov A Mol Imaging Biol; 2017 Apr; 19(2):298-304. PubMed ID: 27552812 [TBL] [Abstract][Full Text] [Related]
54. A deep learning radiomics model for preoperative grading in meningioma. Zhu Y; Man C; Gong L; Dong D; Yu X; Wang S; Fang M; Wang S; Fang X; Chen X; Tian J Eur J Radiol; 2019 Jul; 116():128-134. PubMed ID: 31153553 [TBL] [Abstract][Full Text] [Related]
55. Regrowth factors of WHO grade I skull base meningiomas following incomplete resection. Park HH; Yoo J; Oh HC; Cha YJ; Kim SH; Hong CK; Lee KS J Neurosurg; 2022 Dec; 137(6):1656-1665. PubMed ID: 35453107 [TBL] [Abstract][Full Text] [Related]
56. Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior. Liu Y; Chotai S; Chen M; Jin S; Qi ST; Pan J PLoS One; 2015; 10(3):e0118908. PubMed ID: 25786236 [TBL] [Abstract][Full Text] [Related]
57. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240 [TBL] [Abstract][Full Text] [Related]
58. Resected WHO grade I meningioma and predictors of local control. Nowak-Choi K; Palmer JD; Casey J; Chitale A; Kalchman I; Buss E; Keith SW; Hegarty SE; Curtis M; Solomides C; Shi W; Judy K; Andrews DW; Farrell C; Werner-Wasik M J Neurooncol; 2021 Mar; 152(1):145-151. PubMed ID: 33420897 [TBL] [Abstract][Full Text] [Related]
59. Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping. Zhang S; Chiang GC; Knapp JM; Zecca CM; He D; Ramakrishna R; Magge RS; Pisapia DJ; Fine HA; Tsiouris AJ; Zhao Y; Heier LA; Wang Y; Kovanlikaya I J Neuroradiol; 2020 Jun; 47(4):272-277. PubMed ID: 31136748 [TBL] [Abstract][Full Text] [Related]
60. Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters. Surov A; Gottschling S; Mawrin C; Prell J; Spielmann RP; Wienke A; Fiedler E Transl Oncol; 2015 Dec; 8(6):517-23. PubMed ID: 26692534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]